SWEDISH MEDICAL CENTER
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1910-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.swedish.org/
Phase II Trial of LBH589 in Refractory Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT00690677
- Locations
- ๐บ๐ธ
Swedish Medical Center, Seattle, Washington, United States
Rituxan With or Without Methotrexate in Psoriatic Arthritis
- Conditions
- Psoriatic Arthritis
- First Posted Date
- 2007-07-31
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 6
- Registration Number
- NCT00509678
- Locations
- ๐บ๐ธ
University of Rochester, Rochester, New York, United States
๐บ๐ธSwedish Rheumatology Research, Seattle, Washington, United States
๐บ๐ธUniversity of California, San Diego, La Jolla, California, United States
Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma
- Conditions
- Lung Cancer
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2010-03-04
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 5
- Registration Number
- NCT00456716
- Locations
- ๐บ๐ธ
Swedish Cancer Institute, Seattle, Washington, United States
Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma
- Conditions
- Lung CancerAdenocarcinoma
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2010-10-06
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT00430261
- Locations
- ๐บ๐ธ
Swedish Cancer Institute, Seattle, Washington, United States
Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation
- Conditions
- Immunosuppressant Associated Diarrhea
- Interventions
- Other: PlaceboDrug: Probiotic Supplement
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2011-07-26
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT00364650
- Locations
- ๐บ๐ธ
Swedish Medical Center, Seattle, Washington, United States
Phase II Trial of RAD001 in Refractory Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2006-06-16
- Last Posted Date
- 2007-10-10
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT00337545
- Locations
- ๐บ๐ธ
Swedish Cancer Institute, Seattle, Washington, United States
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer
- Conditions
- Small Cell Lung Cancer
- First Posted Date
- 2006-04-20
- Last Posted Date
- 2007-04-05
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT00316433
- Locations
- ๐บ๐ธ
Swedish Medical Center Cancer Institute, Seattle, Washington, United States
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients
- Conditions
- Stage IV Breast CancerOvarian Epithelial Cancer Stage IIIStage IV Ovarian Cancer
- First Posted Date
- 2006-04-20
- Last Posted Date
- 2011-02-18
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00316407
- Locations
- ๐บ๐ธ
Swedish Medical Center Cancer Institute, Seattle, Washington, United States
๐บ๐ธUniversity of New Mexico Cancer Center, Albuquerque, New Mexico, United States
Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2006-04-20
- Last Posted Date
- 2010-03-08
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT00316420
- Locations
- ๐บ๐ธ
Swedish Medical Center Cancer Institute, Seattle, Washington, United States